In the other, appetitive and non-appetitive morphine discrimination was disrupted by both dopamine receptor agonism and antagonism in male and female rats @Psychopharm

rdcu.be/dDXLN

Had the most delightful discussion w/ Steve about stress, inclusion of females in research, much much more… Yes, I’m full of unsolicited advice😉

Thx Stephen Mahler for the opportunity 🙏!Can’t wait to continue the discussion soon!

& thx @Psychopharm for supporting our work

Happy #PsychopharmPhriday ! As promised, here is a new, exciting, spirited, and big-picture conversation with Dr. Debra Bangasser! Sex, reward, development, stress, and much much more...
Even some unsolicited advice for NIH! #R &R :)
youtu.be/WrmDAmTv3Gs

Psychedelics are not a panacea. They may have substantial potential for benefit for certain individuals under certain circumstances, but they are not without risks. Please share this PSA from Johns Hopkins Psychedelic Research Center!!

Humbly delighted and honored to be part of this great panel of speakers for:
#FENS2024 Eur Behav Pharm Soc. EBBStweets

Ketamine administration (10-30mg/kg) has acute, but not persistent effects on cognitive flexibility or reward processing in a probabilistic reversal learning task in healthy rats
New in #Psychopharm !
link.springer.com/article/10.100…

Microdoses of LSD enhance neural complexity, study finds (by Eric W. Dolan)
Joel Frohlich Dr. Connor Haggarty Royce Lee WSU Pharmacy & Health Sciences Eur Behav Pharm Soc. Institute for Advanced Consciousness Studies Psynautics
psypost.org/microdoses-of-…

Happy #PsychopharmPhriday !
Today's interview is with Stephanie Groman from UChicago Medicine. We discuss what #adolescence is & what its for, and our professional as well as personal interests in neurodevelopment!
youtu.be/5X5Y2098Yoc

We are deeply saddened by the loss of Larry Young, a founder of the Society for Social Neuroscience, a legend in the field, and a brilliant scientist who is loved by many, many members of this society and beyond.

Our #S4SN2025 meeting will be dedicated to the life and memory of Dr. Larry Young! ❤️

Review of the week: excellent (& thoughtful) @Psychopharm paper of S Stevens Negus introducing the
'economon' model of addiction & discuss its implications to prevalence of addiction, the brain-disease model & factors that mitigate or promote addiction
pubmed.ncbi.nlm.nih.gov/38277005/

#FluorescenceFriday
I 🩷the #PVT 😍
image courtesy of @FlagelLab postdoc, Stephanie Desrochers

Happy #Psychopharm Phriday !
New conversation w Terry E Robinson of UMich Biopsychology Michigan Neuroscience Graduate Program
We discuss his 1st (1984) and final (2020) experimental paper in #Psychopharm , sensitization & what it teaches us, addiction models, #dopamine in behavior, & more!
youtu.be/22M5gZRlf5Q

Exciting news from #Vienna ! 🎉

The #FENS Programme Committee Meeting is in full swing putting the final touches to the scientific programme for #FENS 2024! Have you already registered? 😄

Regular registration is open until 14 May!
Learn more: loom.ly/0eQS4lE

Could psychedelics help treat alcohol use disorder? A new clinical trial in #yyc at Hotchkiss Brain Institute (HBI) hopes to find out.

Researcher Leah Mayo says psychedelics open 'a therapeutic window of opportunity.'

Full Interview: globalnews.ca/video/10373269…

New in #Psychopharm : influences of anabolic steroid use in male weightlifters on facial emotion recognition: Our findings demonstrate impaired facial emotion recognition among men currently using AAS compared to controls.
link.springer.com/article/10.100…

Does the Gut-Heart-Brain-Axis play an underappreciated role in Psychopathology? See this provocative review on 'Psychocardiology' in the new issue of #Psychopharm
link.springer.com/article/10.100…

📣 Exciting News for ALBA Members! 🌟One grant in the ACNP Travel Award program is earmarked for an ALBA member working in the field of #neuropsychopharmacology . Don't miss out on this opportunity to attend #ACNP2024 & connect with leaders in the field. Apply now!…

New in #Psychopharm , see this meta-analysis examining how #varenicline #Chantix influences fRMI signals of nicotine withdrawal--some responses are sensitive to this front-line smoking cessation drug, others are not.
link.springer.com/article/10.100…

The #BrainAwarenessWeek 2024 is coming to an end! 🧠

We hope you enjoyed the #BrainWeek projects! Share your experience in the comments ⬇️ and keep following FENS for more! 🎉

FENS BAW projects were funded by #FENS with the generous support of the Dana Foundation🧠.

😍 #BrainAwarenessWeek Day 6!

Don't miss more exciting #BrainWeek activities!

🧠 Check out all of our awardee projects here: loom.ly/x27MPcU

FENS BAW projects are generously supported by the Dana Foundation🧠.